Philip Morris
Environmental Tobacco Smoke and Mortality A Detailed Review of Epidemiological Evidence Relating Environmental Tobacco Smoke to the Risk of Cancer, Heart Disease and Other Causes of Death in Adults Who Have Never Smoked - 5 Heart Disease
Fields
- Author
- Lee, P.N.
- Document File
- 2023511660/2023512308/Ets: Heart Disease 930900
- Master ID
- 2023511661/2307
Related Documents:- 2023511661-2307 Environmental Tobacco Smoke and Heart Disease
- 2023511710 the Relationship of Passive Smoking to Various Health Outcomes Among Seventh-Day Adventists in California.
- 2023511714-1718 Passive Smoking and the Risk of Heart Attack or Coronary Death
- 2023511722-1727 Effects of Passive Smoking on Ischemic Heart Disease Mortality of Nonsmokers A Prospective Study
- 2023511728 Erratum
- 2023511729 'effects of Passive Smoking on Ischemic Heart Disease Mortality of Nonsmokers: A Prospective Study'
- 2023511730 the First Author Replies
- 2023511734-1737
- 2023511738-1744 Passive Smoking in Females and Coronary Heart Disease
- 2023511749-1756 Original Contributions Heart Disease Mortality in Nonsmokers Living with Smokers
- 2023511760-1781 Lung Cancer in Japan: Effects of Nutrition and Passive Smoking
- 2023511785-1789 Passive Smoking and Cardiorespiratory Health in A General Population in the West of Scotland
- 2023511790 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511791-1792 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511793-1795 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511800-1802 Public Health Briefs Passive Smoking and 20-Year Cardiovascular Disease Mortality Among Nonsmoking Wives, Evans County, Georgia
- 2023511806-1816 Relationship of Passive Smoking to Risk of Lung Cancer and Other Smoking-Associated Diseases
- 2023511818 Increased Incidence of Heart Attacks in Nonsmoking Women Married to Smokers
- 2023511822-1824 Cvd Epidemiology Newsletter
- 2023511829-1841 Original Contributions Effects of Passive Smoking in the Multiple Risk Factor Intervention Trial
- 2023511842 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511843-1844 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511845 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511846 the Authors Reply
- 2023511849-1853 Smoking As A Risk Factor for Cerebral Ischemia
- 2023511857-1862 Urinary Cotinine Measurement in Patients with Buerger's Disease - Effects of Active and Passive Smoking on the Disease Process
- 2023511865-1881 An Estimate of Adult Mortality in the United States From Passive Smoking
- 2023511882 Editorial Cardiovascular Risks of Environmental Tobacco Smoke
- 2023511883-1887 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511888-1890 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511891-1892 Ischemic Heart Disease: Response to Lee
- 2023511893-1895 Rebuttal to Lee / Katzenstein Commentary on Passive Smoking Risk
- 2023511896-1899 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511900-1906 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response to Criticism
- 2023511908-1911 Deaths From Lung Cancer and Ischemic Heart Disease Due to Passive Smoking in New Zealand
- 2023511912 Deaths From Lung Cancer and Ischemic Heart Disease Due to Passive Smoking in New Zealand
- 2023511913 Passive Smoking in New Zealand
- 2023511914 Passive Smoking in New Zealand
- 2023511915 Passive Smoking in New Zealand
- 2023511916 Passive Smoking and Passive Thinking
- 2023511918-1937 Cardiovascular Diseases and the Work Environment A Critical Review of the Epidemiological Literature on Chemical Factors
- 2023511939-1950 Clinical Progress Series Passive Smoking and Heart Disease Epidemiology, Physiology, and Biochemistry
- 2023511952-1957 Review Passive Smoking and the Risk of Heart Disease
- 2023511958-1961 Aha Medical / Scientific Statement Position Statement Environmental Tobacco Smoke and Cardiovascular Disease A Position Paper From the Council on Cardiopulmonary and Critical Care, American Heart Association
- 2023511965-1983 the Health Consequences of Involuntary Smoking A Report of the Surgeon General
- 2023511985-1998 Environmental Tobacco Smoke Measuring Exposures and Assessing Health Effects
- 2023512000-2015 Environmental Tobacco Smoke Proceedings of the International Symposium at Mcgill University 890000 Environmental Tobacco Smoke and Cardiovascular Disease: A Critique of the Epidemiological Literature and Recommendations for Future Research
- 2023512016-2028 Panel Discussion on Cardiovascular Disease
- 2023512030-2037 Indoor Air Quality and Ventilation Environmental Tobacco Smoke (Ets) and Cardiovascular Disease
- 2023512039-2054 A Critique of the Methods Used to Assess the Toxic Effects on Man of Combustion Products.
- 2023512056-2066 Coronary Heart Disease and Involuntary Smoking
- 2023512068-2077 7. Environmental Tobacco Smoke and Coronary Heart Disease
- 2023512079-2088 Environmental Tobacco Smoke and Coronary Heart Disease
- 2023512090-2091 Editorial Give A Dog-End A Bad Name
- 2023512093-2108 Weaknesses in Recent Risk Assessments of Environmental Tobacco Smoke
- 2023512131-2155 Environmental Tobacco Smoke Exposure and Occupational Heart Disease
- 2023512157-2171 Passive Smoking and Coronary Artery Disease. Biological Plausibility and Severity of Effect
- 2023512173-2180 Carbon Monoxide and Cardiovascular Disease: An Analysis of the Weight of Evidence
- 2023512185-2189 the Effects of Passive Inhalation of Cigarette Smoke on Excercise Performance
- 2023512192-2195 Effect of Passive Smoking on Angina Pectoris
- 2023512199-2202
- 2023512203-2213 Effect of 'passive' Smoking on the Physical Load Tolerance of Coronary Heart Disease Patients
- 2023512216-2220 Indoor Passive Smoking: Its Effect on Cardiac Performance
- 2023512223-2224 Passive Smoking Severely Decreases Platelet Sensitivity to Antiaggregatory Prostaglandins
- 2023512227-2230 Platelet Sensitivity to Prostacyclin in Smokers and Non-Smokers
- 2023512233-2237 Besitzen Passivraucher Ein Erhohtes Thromboserisiko?
- 2023512241-2244 Passive Smoking Affects Endothelium and Platelets
- 2023512247-2253 Lipoprotein and Oxygen Transport Alterations in Passive Smoking Preadolescent Children the Mcv Twin Study
- 2023512256-2257 Abstracts of the 30th Annual Conference on Cardiovascular Disease Epidemiology Children's Hdl-Chol: the Effects of Tobacco: Smoking, Smokeless and Parental Smoking
- 2023512261-2266 Passive Smoking Alters Lipid Profiles in Adolescents
- 2023512269-2274 Serum Lipids & Lipoprotein Profiles of Cigarette Smokers & Passive Smokers
- 2023512278-2279 8th Worldconference on Tobacco or Health Building A Tobacco-Free World 920330 - 920403 Buenos Aires - Argentina Abstracts, Posters and Videos. Serum Lipoproteins in Nonsmokers Chronically Exposed to Tobacco Smoke in the Workplace
- 2023512282 the Association Between Carotid Arterial Wall Thickness and Active and Passive Cigarette Smoking
- 2023512285 Passive Smoking and Carotid Artery Wall Thickness: the Aric Study
- 2023512290-2297 Passive Smoking Increases Experimental Atherosclerosis in Cholesterol-Fed Rabbits
- 2023512300-2301 Supplement to Circulation Abstracts From the 65th Scientific Sessions New Orleans Convention Center New Orleans, Louisiana 921116 - 921119
- 2023512304-2307 Association of Passive Smoking with Increased Coronary Heart Disease Risk Is Not Explained by Elevation of Leucocyte Count
- Site
- R529
- Type
- PSCI, PUBLICATION SCIENTIFIC
- BIBL, BIBLIOGRAPHY
- CHAR, CHART, GRAPH, TABLE, MAPS
- BIBL, BIBLIOGRAPHY
- Named Organization
- Library of Congress
- Area
- SCIENTIFIC AFFAIRS/BLACK LATERAL OLD S&T
- Characteristic
- EXTR, EXTRA
- MISS, MISSING PAGES
- Litigation
- Okag/Privilege Withdrawn
- Okag/Produced
- Date Loaded
- 24 May 1999
- UCSF Legacy ID
- wic02a00
Document Images
I
r
:
I
,
r
P.N. Lee
Environmental
Tobacco SmOke
and Mortall"ty
A Detailed' Review of Epidemioiogicat Evidence Relating Environmental
Tobacco Smoke to the Risk of Cancer, Heart Disease and Other Guses
of Death in Adults Who Have Never Smoked
101 tables, 1992
K/~\RGER
Easel Munehen Paris l ondon NeW York Nrr Delhi Banskok Sinpporo -Tokyo
Sydne)
2023512110
®

Library of Congress Cataloging-inPubhcation Data
Lec. Pcter N., 1943-
Environmental tobacw smoke and morulny; a detailed reviovu or epidemiological evidence
rolating environmental tobacco smoke to the nsk of cancer, heart disease- and other wuses of'
death in ad'ults who have nevcr smoked'J P.N. Let.
Includes bibliograpfiicnl references and index
1I Passive smoking - Health upects., 2. Tobacaosmoke pollution - Health aspects.
3. Environmentally induced diseases-Tozioology. L Tttle.
(DNLM: 1. Cause of Dcath, 2~: Hean Diseases - epidcmiolog. 3. Heart Diseases -
mortality, f. Neoplasms-epidemiolbgy. S. Neoplasms-mortahq. 6. TobaccoSmoke
Pollution -adverx effects: w'A 754 U7g5eji
RA12t2 T6L4, 1992 615.9'52379 -dc20
ISBN 3-d055-5529-6
All rights rsserved..
No pan of this publiation may be tnnslated into othenlanguaaesr reproduced or utilized in
any form or by any means, eknronic or mechanicaL incJudrng photowpyirrt. eeoording,
miesocopying. or by any information storage and retrieval system, without permission ie
writing from the pubhshcr,
O Copyright 1992 by S. Karger AG. P.O. Bo:.,CH-s009 Base1 (Switzerland)
Printed in Switzerland on acid-free paper, by Thur AG OfRctdrudc, Praaela
ISBN 3-4055-5529-1>

I
I
I
h
I
i
Contents
lndez to Tables ....................................... X
.
Preface ........................................... XV
Acknowledgemenu ..................................... XX
1 I ntroduction
1.1 Background and Objectives . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I
1.2 Terms of Reference . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
1.3 Structure of This Book . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
1.4 Problems of Inference from Epidemiological Studies . . . . . . . . . . . . . . . . . 4
1.5 Dosimetri.c Considerations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
1.6 Misclassification of Active Smoking Status . . . . . . . . . . . . . . . . . . . . . . . 7
2 The 53 Studies
2.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . 9
2.2 Prospective Studies . . . . . . . . . . . . . . . . . . . . . . . . . . . ., . . . . . . . . 9
2?:1 Amerinn Cancer Society Million Person Study - Garfinkel I . . . . . . ., . . . . . 9
2.2.2 !!apanese Study - Hirayama . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11.
2:2:3 Wcst ofScotland Study - Hole . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . l5
2.2.4 Alameda County Study - Reynolds . . . . . . . . . . . . . . . . . . . . . . . . . . . 1!8
2.2.5 Rancho Bernardo Study - Garland . . . . . . . . . . ., . . . . . . . . . . . . . . . . 19 '
2.2.6 Multipte Risk Factor, Intervention Trial - Svendsen ., . . . . . . . . . . . . . . . . 20
2.2.7 Washington County Study - Sandier 11 . ., ., . . . . . . . . ., . . . . . . . . . . . . . 22'
2.2.8 Amsterdam Study- Vandenbroucke . ., . . ., ., ., . ., . . . ., ., . . . . ., . ., . . . . . 25
2.2.9 Georgia Study - Humble II . ., . . . . . . . . . . ., . . . . . . . . . . . . . . . . . .
25
2.2.10 Californian Seventh-Day Adventists Study - Butler . . . . . . . . . . . . . . . . . . 26
2.3 Gse-Control Studies of Mor¢ than One Disease . . . . . . . . . . . . . . . . . . . ., 27
2.3.1 United' Kingdom Study - Lee . . . . . . . . . . . . . . . . . . . . . . . . . . . . ., . 27
2.3.2 North Carolina Study - Sandler I . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
2.3.3 Erie County Study of Cancer of All Sites - Miller . . . . . . . . . . . . . . . . . . . 32
2:4 Case-Control Studies of Lung Cancer . . . . . . . . . . . . . . . . . . . . . . . . . . 34
2:A:1 Japanese Atomic Bomb Survivors Study- Akiba . . . . . . . . . . . . . . . . . . . 34
2:4.2 Southern Swedish Study - Axelson . . . . . . . . . . . . . . . . . . . . . . . . . . 35

2.4.3 Colondo Studv of Adenocarcinoma - Brownson . . . . . . . . . . . . . . . . . . . 36
2.4.4 Texas Study - Buffier . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
2.4.5 First Hong Kong Study - Chan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37
2.4.6 Louisiana Study - Corrca . . . . . . . . . . . . . ., . . . ., . . . . . . . . . . . . . . . U
2.4.7 Shanghai Study- Gao . . . . . ., . ., . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
2.4.8 New JeneylOhio Study - Garfinkel II . . . . . . . . . . . . . . . . . . . . . . . . . . 40
2.4.9 Tianjin Study - Geng . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
2.4.10 New Mexico Study - Humble I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
2.4.11 Kanagawa Study - I'noue . . . . . . . . . . ... . . . . . . . . . . . . . . . . . . . . . 45
2.4.12 First New York Study - Kabat I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47
2.4.13, Third New York Studv - Kabat Il l . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
2.4.14 Socond Athens Study - Kalandidi IJ . . .. . . . . . . . . .. . . . . . . . . . . . . . . 49
2:4.1!5 Nara Study - Katada . . . . . . . . .. .. . . . . . . . . . . . . . . . . . . . . . . .
. . S I'
2:4'.16 German Studv - Knoth ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . 52
2.4:17 Second Hong Kong Study - Koo . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 53
2.4.18 Third Hong Kong Study - Lam 1 . . . . . . . . . . . . . . . . . . . . . . . . . . .. .. 55
2.4.19 Fourth Hong Kong Study - Lam 11 . . . . . . . . . . . . . . . . . . . . . .. . . . . . 56
2.4.20 Shanghai Study, - Li . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . 57
2.4.21 Armadale Study - Uoyd . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57
2.4.22 Swedish Study - Pershagen . . . . . . . . . . .. . .. .. . . .. . .. . . . . . . . . . . .
. . 58
2.4.23 Nagoya Study - Shimizu . ., . . ., . ., . . ., ., ., . . . . . . ., . . . . . . . . . - . .
. . 59
2:4.24 Osaka Study - Sobue . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60
2.4.25 Stockholm Study - Svensson . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62
2.4.26 Athens Study - Triehopoulos . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 63
2.4.27 Second New York StudN - Varcla . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65
2.4.28 Hyrbin Study of Adenocarcinoma - Wang . . . . . . . . . . . . . . . . . .. . . . . . 68
2.4.29 Los Angeles Study - W,w . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 68
2.4.30 North-East China Study - Wu-Wiiliarns . . . . . . . . .. . . . . . . . . . . . . . . . 69
2.4.31 New Jersey Study - Ziegler . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 72
2.5 Case-Control Studies of Bladder Cancer . . . . . . . . . . . . . . . . . . . . . . . . 73
2.5,1 Canadian Study - Burch . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 73
2.5:2 US Study - Kabat 11 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 73
2.6 Casc-ControliStudies of Cervix Cancer . . . . . . . . . . . . . . . . . . . . . . . . . 75
2.6.1 Gothenburg Study - Hellberg . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75
2.6.2 Utah Study - Slattery . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75
2:7 Case-Control Studies of Heart' Disease . . . . . . . . . . . . . . . . . . . . . . . . . 77
2.7.1 Chinese Study - He . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 77
2.7:2 Utah Study- Martin . . . . . . . . . . . . . . . . ., . . ., ., . . . . . . . . ... ..... . 79
2.7.3 US Study- Palmer . . . . . . . . . . . . . . . . . . . . . . . . . . . . ., . ., . . . . . 79
2.8 Case-Control Study of Chronic Obstructive Pulmonary Disease . . . . . . . . . . . 801
2.8.1 Greek Study - Kalandidi I . . . . . . . . . . . . ., . . . ., . . . . . . . . . . . . . . . 80
,
2.9 Case{ontrol Study of Stroke ............................... , , 82
2.9.1 Australian Study - Donnan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 82

I
I
ii
Contents
3 Lung Cancer
VII
3.1 Seleaion of Studirs for Detailed Consideration .................... $3
3.2 Features of the 29 Studies Included . . . . . . . . . . . . . . . . . . . . . . . . . . . 83
3.2:1 Study Design . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
83
.
3.2.2 (i.ocation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. 84
3:2.3 Time of Death/Diagnosis . . . . . . . . . . . . . . . . . . . . . . . . . . ., . . . . . $4
3:2.4 The Cases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
84
3.2.5 The Controls . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ., ., . . . . . . .
88
3.2.6 Sources or Information . . ., ., . . . . . . . . . . . ., . . . ., . . . . . . . . . . . . . .
93
3.2.7 Non-Response . . . . . . . . . . . . . . . . ., . . . . . . . . . . . . . . . . . . . . . 95
3.2.8' indices of ETS Exposure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 95
3.2.9 Smoking Status of the Subjects . . . . . . . . . . . . i . . . . . . . . . . . . . . . . . 98
3.2.10 Confounding Variablt:s . . . . . ., . . . . . . . . . . . . . . . . . . . . . . . . . . . .
101
3.3 Summary of Results from the 29 Studies . . . . . . . . . . . . . . . . . . . . . . . . 101
3.3.1 Main Index - Spouse Smoking or Nearest Equivalent . . . . . . . . . .. . .. . .. . . 101
3.3.2 Histological: Type of Lung Cancer . . . . . . . . . . . . . . . . . . . . . . . . . . ., . 109
3.3.3 l.eveUof Exposure ., . . . . ... . . . . . . . . . . . . . . . . . . . I1 l,
3.3.4 Variation in Relative Risk According to Other Factors . . . . . . . . . . . . . . . . 113
3.3.5 Other Indices of ETS Exposure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 115
3.3,6 'Attributable Risk' from ETS Exposure . . . . . . . . . . . . . . . . . . . . . . . . . 119
3.3.7 Comparability of Associations with ETS Exposure and Active Smoking ...... 123
3.4 bnter9reution of the Findings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 124
3:4.1 The Main Findings . . . . . . . . . . . . . . . . . . . . . . ., . . . . 1,24
3.4.2 Plausibility . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
125
3.4.3 Explanations to Be Considered . . . . . . . . . . . . . . . . . . ., . . . . . . . . . . . 127
3.4.4 Misclassification of Diagnosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 128
3.4.5 Misciassifintion of ETS Ezposure . . . . . . . . . . . . . . . . . . . . . . . . . . . . 129
3.4.6 Lack of Comparability of Cases and Controls . . . . . . . . . . . . . . . . . . . . . 130
3.4.7 Other Study Weaknesses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 132
3:4: 8 Confounding . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 133
3.4'.8.1' Age . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. ., 133
3.4.8.2 Marital Status . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ., ., . . . . .
. 134
3.4.8.3 Other Confounding Factors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
135
3.4.8.4 Conclusions Regarding Confounding . . . . . . . . . . . . . . . . . . . . . . . . . . 142
3.4.9 Misclassification of Active Smoking Status . . . . . . . . . . . . . . . . . . . . . . . 142
3.4.9.1 The Problem . . . . . . . . . . . . . . ... . . .. . . . . . . . . . . . . . . .. . ., . . .
. 142
3.4.9.2 Major and Minor Sourtxs of Bias . . . . . . . . . . . . . . . . . ., ., . . . . . . . . .
143
3.4.9.3 What I,eve1 of Misclassification Would Be Needed to Enplain~the Observed
Associations of Spouse Smoking with Lung Canoer7' . . . . . . . . . . . . . . . . . 146
3.4.9.4 Evidence on Extent of Misclassification . . . . . . . . . . . . . . . . . . . . . . . ., .,
150
3.4.9.5 Evidence on Extent of Smoking Habit Concordance . . . . . . . . . . .. . .. . . . . 158
3.4.9.6 Conclusions Regarding Misclassi6aation . . . . . . . . . . . . . . . . . . . . . . . . 162
3.4.10 Publintion Bias and Other Issues in Meta-Analysis . . . . . . . . . . . . . . . . . . 164
3.5 Overall Assessment of the Evidence on ETS and Lung Caneer; ........... 166
202351209:114

V1I1 Contents
4 Other Cancers
4.1 Studies Providing Data .................................. . 168
4.2 Results ., . . . . . . . . . . ., . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
168
4.2.1 Weaknesses of Some Studies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 168
4.2.2' Ovcrall Risk . . . . . . . . . . . . . . . . . . . . . . . . . . ., . . . . . . . . . . . . .
169
4.2.3 Lip: Oral Cavity and Pharynz . ., . . . . . . . . . . . . ., . . . . . . . . . . . . . . . 172
4.2.4 Digestive System . . . . . . . . ., . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
173
4.2.5 Respiratory Sites Other Than the Lung . . . . . . . . . . . . . . . . . . . . . . . . . 174
4.2.6 Bone, Connective Tissue and Skin . . . . . . . . . . . . . . . . . . . . . . . . . . . . 174
4.2.7 Breast . . . . . ., . . . . . ., . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . .
. . 175
4.2.8 Female Genital System. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 176
4.2.9 Male Genital System . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 178
4.2.10 Unnary Tract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .~ . . . . . .
II79
4.211 Eyc, Brain and Nervous System . . . . . . . . . . . . . . . . . . . . . . . . . . . . ., 179
4.2.12 Endocrine Glands . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ., . . .
180
4.2.13' Lymphatic and Haematopoictic Tissue . . . . . . . . . . . . . . . . . . . . . . . . . 180
4.2.14: Other Cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
181
4.3 Discussion and Conclusions . . . ., . . . ., . . . . . . . . . . . . . . . . . . . . . . . 181
5 Heart Disease
5,1 Studies Providing Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 184
5.2 Features of the Studies Included . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 184
5.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
186
5.4 Discussion and Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . ., . . 193
6 Other Diseases
6.1 Studies Providing Data . . . . . . . . . . ., . . ., . ., . ., . . . . . . . . . . . . . . . .
197'
6.2 Results . . . . . . . . . . . . ., ., . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
197
6.2.1 Tuberculosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ., . . . . . . . . . .
197
6.2.2 Diabetes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ., . . . . . . . .
. 197
6.2.3 Cerebrovascular Disease . . . . . . . . . . . . . . . . . . . . ., . . . . . . . . . . . . 198
6.2.4 Respiratory Diseases . . . . . . . . . . . . . . . . . . . . ., ., . . . . . . . . . . . . .
199
6,2.5 Diseases of the Digestive System . . . . . . . . . ., . . . . . . . . . . . . . . . . . . 200
6.2.6 Gastro-Iotestinal1 Ulcer . . ., ., . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
200
6.2.7 Cirrbosis of the Liver . . . ., ., . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
201
6.2.8 Diseases of the Genito-Urinary System . . . . . . . . . . . . . . . . . . . . . . . . . 201
6.2.9 Accidental Causes of Death . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 201
6.2.10 Suicide . . . . ., . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. 201.
6.2.11 Ot her Diseases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
201
6.3 Discussion and Conclusions . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 202

Contents
7 Overall Risk of Mortality
Ix
7.1 Studies Providing Data .................................. 203
7.2 Results ........................................... , 203
7.3 Discussion and Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . .
201
8 Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 208
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 210
Subject Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21'8'
h.

-1
)
Heart Disease
5.1 Studies Providing Data
i
Eleven studies have provide& information on the relationship ofl ETS to
risk of cardiovascular disease. Seven of these are prospective studies, 5
eonducted in the USA (Butler, Garland, Humble 11, Sandler 11, Svendsen),
I in Japan (Hirayama) and I in Scotland (Hole). Four are case-control
studies, 2 in the USA (Martin, Palmer), I in China (He) and I in England
(Lee).
Three prospective studies which have reported results for lung cancer
(Garfinkel I), totat cancer (Reynolds) or all-cause mortality (Vanden-
broucke) have not reported results for heart disease. While the numbers of
deaths would not be substantial for the last 2 studies. the fact that the
first, the American Cancer Society million person study has not provided
information is a wastage of resource. This study alone would certainly
have had data on more deaths/cases than all! the i l published studies
combined!
5:2 Eeatures of the Studies Included
It should be noted that very little information is available for 3 of the 1 L
studies considered: the prospective study of Butler, and the case-control
studies of Martin and Palmer for which the only published data consist of
abstracts.
The number of deaths/cases in some studies is verv small. There are 4
studies with extremely small numbers (Svendsen, 13; Garland, 19; Martin,
23; He, 34)4 with quite small numbers (Humble II, 76; Butler, 80; Hole,
84; Lee, l18), and 1' (Paltner, 336 in ever smokers and never smokers
combined) which, though of moderate size, has not presented findings in a
form~to allow proper evaluation. Considering the prevalence of heart dis-

5 Hean Dssease 185
ease among never smokers - very much higher than from lung cancer - it is
surprising that by now there are only 2 published' studies for reporting
results based on reasonably substantial numbers of deaths/cases (Hiraya-
ma, 494; Sandier It 1,358).
Of the 7 prospective studies, 4 involved study subjects attending for
an examination during which blood pressure, cholesterol and body mass
index were measured. It is unfortunate that neither of the 2 substantial
studies collected information on these classical risk factors for heart dis-
ease. The factors used by the authors for adjustment - occupation by
Hirayamaand schooling; housing quality, and marital status by Sandler I1
- are not those which firstoccur as being most relevant in a study of heart
disease.
Some of the studies have problems regarding representativeness of the
subjects. Thus in both the Garland and Hole studies, about 20% of the
population did not attend for examination, with a possibility of bias if
failure to attend was associated both with ETS exposure and risk of death
from heart disease. ln the large Sandier lt study, only deaths in Washing-
ton County were recorded, again imparting a danger of bias if ETS is
associated with the chance of migration out of the county. The Svendsen
study, was based on the well-known Multiple Risk Factor Intervention
Trial, which involved people at very high risk of heart disease base& on
their smoking, blood pressure and cholesterol levels. Since the paper con-
cerned never smokers, all the subjects involwed most probably exhibited
abnormally high blood pressure and'/or cholesterol levels. The Butler study
involved Seventh-Day Adventists, an atypical population with regard to
many variables.
The 2 studies which provided data on by far the largest number of
deaths are both open to criticismas detailed in sections 2.2.2 (Hirayama)
and 2.2.7 (Sandler 1~1), and also in section 4.2:1. It is interesting to note that
both studies have publishe& inconsistent results for women. In 1981,
Hirayama presented results showing no association of heart disease with
husband smoking, based on follow-up of his population to 1979. In 1984,
he reported results which showed a significant association, based on fol,
low-up of his population to 1981. These results implied an implausibly
strong relationship of heart disease to smoking by the husband when
deaths occurring in 1979-81 were considered (a fact pointed out by Lre in
correspondence in the New Zealand MedicalJoarnal [26, 27J). As a result,
Hirayama published revised figures for follow-up to 1979, indicating that
the data published in 1981 were incorrect.

166 Environmental,TobacooSmoke and Morulitj
Helsing et al. [40]I and Sandier et al. [43] have both presented (in
Table 4 of each paper) results for risk of arteriosclerotie heart disease in
relation to ETS exposure. Based' on ddentical numbers of deaths an&stated
adjustment factors, the reported relative risks and confidence limits for
men were identical. Inexplicably, however, this was not the case for wom-
en, where relative risks and' confidence limits both varied. Given the rela-
tively larger contribution of the Hirayama an& Sandler II results to the
overall number of heart disease cases studied4 such~diffcrenccs in reported
findings are rather disconcerting.
53 Results
Table 5.1 summarizes results for exposure to ETS from the spouse or in the
household. Before considering the findings, some points are worth not-
ing:
(i) As far as can be ascertained, alli the relative risks are for never smok-
ers.
(ii) The index was based on smoking by the spouse in 7 studies (Butler,
Garland; He, Hirayama, Humble il, Lee, Svendsen), only married
women being considered, except perhaps in the Chinese study where
single women were included with the wives of non-smoking husbands.
In 2 studies (Tvlartin, Palmer) thc index used is not known. The Hole
study compared people living at the same address as a study partici-
pant who had ever smoked with people who lived arthe same address
as a study participant who had never smokedl with no other studyy
participant at that address ever having smoked. The Sandler 11, , stud.
used a complex index of exposure, but for the results in Table 5.1 it
amounted to a comparison of people living in the household where
some adult had ever smoked with people in a household' where no
adult had' ever smoked.
(iii) When a study has presented different findings at different time points
for apparently the same comparison, the later publication has been
used, namely, Hirayama [23) and not his 198'I paper [2), and Sandier
et al. [43) and not Helsing et al. (40):
(iv) Ifi the authors have presented adjusted relative risks these have nor-
mally been given in Table 5: f. There are some exceptions. First, the
relative risk of 14.9 by Garland et al. [38), adjusted for age, systolic
blood pressuretotal cholesterol, obesity index and years of marriagc,
